Contribution of mass spectrometry to contemporary immunology.
about
Immunoproteomics: Mass spectrometry-based methods to study the targets of the immune responsePrimary structure details of haptoglobin alpha chain proteins from human plasma samples are resolved by matrix-assisted laser desorption/ionization quadrupole ion trap time-of-flight multiple-stage tandem mass spectrometry sequencing.Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS.Development of a Chlamydia trachomatis T cell Vaccine.Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cells.Tumor antigens and proteomics from the point of view of the major histocompatibility complex peptides.Outer membrane proteins preferentially load MHC class II peptides: implications for a Chlamydia trachomatis T cell vaccine.The potential of proteomics and peptidomics for allergy and asthma research.Determination of protein-derived epitopes by mass spectrometry.Contribution of mass spectrometry-based proteomics to immunology.Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications.MHC class I antigen presentation and implications for developing a new generation of therapeutic vaccines.Using MHC Molecules to Define a Chlamydia T Cell Vaccine.Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse.Stable isotope tagging of epitopes: a highly selective strategy for the identification of major histocompatibility complex class I-associated peptides induced upon viral infection.Obtaining more accurate Fourier transform ion cyclotron resonance mass measurements without internal standards using multiply charged ions.
P2860
Q28238379-0E2A95AA-D282-468E-A439-648760A1B16EQ31075944-D168A166-099E-4BBE-97D0-78EF0CF8B577Q33222048-DE79DF6D-B640-4B1F-9ED1-BBB28AACA877Q34663987-E4F0170E-2014-4E07-8FAE-5AEA818DAEB0Q34773772-55FA08C2-6BA3-43E9-9697-FBD5B7E6055AQ35160569-8634CBD5-6678-4DE8-8158-04DAEA416C37Q35329559-2B8F38C9-88D3-4DA2-A7D3-E5B4C3E440BBQ36245780-82FF7075-02D0-4463-A92D-43ABBF5DD103Q36279073-24696DA8-A75D-4C71-99BF-40143421311EQ36689114-87271A44-17AE-4609-B2AE-588978C2C2C5Q36795668-3AB40E94-B122-4197-B18F-5116849EB472Q37709626-58750C04-93FE-4891-A431-C99E44AD2804Q37836771-E3EB508A-96C5-45BB-BFFC-08DB9CBCD5F4Q38093572-D8473F71-671F-48BB-8462-5D81FE16D70BQ43882094-D691EE6C-A0E0-482E-BD92-B6FC5DAC10ADQ52079180-1909B6E9-41D4-4F5D-B319-621B7031157C
P2860
Contribution of mass spectrometry to contemporary immunology.
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Contribution of mass spectrometry to contemporary immunology.
@ast
Contribution of mass spectrometry to contemporary immunology.
@en
type
label
Contribution of mass spectrometry to contemporary immunology.
@ast
Contribution of mass spectrometry to contemporary immunology.
@en
prefLabel
Contribution of mass spectrometry to contemporary immunology.
@ast
Contribution of mass spectrometry to contemporary immunology.
@en
P2860
P1476
Contribution of mass spectrometry to contemporary immunology.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1098-2787(1998)17:5<311::AID-MAS1>3.0.CO;2-E
P577
1998-09-01T00:00:00Z